Drug Shortage Report for VISUDYNE
Report ID | 123386 |
Drug Identification Number | 02242367 |
Brand name | VISUDYNE |
Common or Proper name | verteporfin |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | VERTEPORFIN |
Strength(s) | 15MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 15ml |
ATC code | S01LA |
ATC description | OCULAR VASCULAR DISORDER AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-01 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-01-05 |
Shortage status | Resolved |
Updated date | 2022-02-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-06-07 | English | Compare |
v10 | 2021-06-07 | English | Compare |
v9 | 2021-06-07 | English | Compare |
v8 | 2021-06-07 | English | Compare |
v7 | 2021-05-13 | French | Compare |
v6 | 2021-05-13 | English | Compare |
v5 | 2021-05-13 | French | Compare |
v4 | 2021-05-13 | English | Compare |
v3 | 2020-11-01 | English | Compare |
v2 | 2020-08-31 | French | Compare |
v1 | 2020-08-31 | English | Compare |